JUNIUS DANIEL M
SEC CIK 1094159 · EDGAR
BoughtSold
Most active insiders at IDXX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | — | $15.34M |
| 2 | Hunt Nimrata | EVP | — | $9.53M |
| 3 | FENNELL GEORGE | EVP | — | $7.34M |
| 4 | Erickson Michael G | EVP | — | $3.37M |
| 5 | Kingsley Lawrence D | Dir | — | $1.17M |
| 6 | Vandebroek Sophie V. | Dir | — | $920.3K |
| 7 | Emerson Andrew | EVP, CFO, Treas | — | — |
| 8 | Schreck Michael | EVP | — | — |
| 9 | Johnson Michael Perkins | EVP | — | — |
| 10 | Peacock Karen | Dir | — | — |
| 16 | JUNIUS DANIEL M | Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-11 17:10 | 2026-05-07 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | M - OptEx | $0.00 | +257 | 3,561 | +8% | $0 |
| DM | 2025-05-14 | 2025-05-13 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | M - OptEx | $263.81 | +2,683 | 4,708 | +132% | +$707.8K |
| D | 2025-05-14 | 2025-05-13 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | S - Sale+OE | $506.41 | -2,683 | 3,304 | -45% | -$1.36M |
| D | 2025-05-08 | 2025-05-06 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | M - OptEx | $0.00 | +262 | 3,304 | +9% | $0 |
| 2024-04-02 | 2024-03-29 | CBIO | CRESCENT BIOPHARMA, INC. | JUNIUS DANIEL M | Dir | A - Grant | $3.00 | +5,209 | 98.5K | +6% | +$15.6K | |
| 2024-02-01 | 2024-01-30 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | A - Grant | $521.03 | +14 | 3,042 | +0.5% | +$7,294 | |
| 2023-11-01 | 2023-10-30 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | A - Grant | $396.39 | +19 | 3,028 | +0.6% | +$7,531 | |
| 2023-08-01 | 2023-07-28 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | A - Grant | $552.78 | +14 | 3,009 | +0.5% | +$7,739 | |
| 2023-05-11 | 2023-05-10 | CBIO | CRESCENT BIOPHARMA, INC. | JUNIUS DANIEL M | Dir | P - Purchase | $1.56 | +30.0K | 93.2K | +47% | +$46.8K | |
| 2023-05-02 | 2023-04-28 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | A - Grant | $492.16 | +13 | 2,995 | +0.4% | +$6,398 | |
| D | 2023-02-17 | 2023-02-16 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | M - OptEx | $206.62 | +2,187 | 5,169 | +73% | +$451.9K |
| D | 2023-02-17 | 2023-02-16 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | S - Sale+OE | $511.68 | -2,187 | 2,982 | -42% | -$1.12M |
| 2023-02-01 | 2023-01-30 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | A - Grant | $482.95 | +14 | 2,982 | +0.5% | +$6,761 | |
| D | 2022-12-07 | 2022-12-05 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | M - OptEx | $160.28 | +3,046 | 6,014 | +103% | +$488.2K |
| D | 2022-12-07 | 2022-12-05 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | S - Sale+OE | $424.91 | -3,046 | 2,968 | -51% | -$1.29M |
| 2022-11-18 | 2022-11-17 | CBIO | CRESCENT BIOPHARMA, INC. | JUNIUS DANIEL M | Dir | P - Purchase | $1.87 | +20.0K | 63.2K | +46% | +$37.4K | |
| 2022-11-01 | 2022-10-28 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | A - Grant | $364.28 | +18 | 2,968 | +0.6% | +$6,557 | |
| 2022-08-02 | 2022-07-29 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | A - Grant | $399.18 | +16 | 2,950 | +0.5% | +$6,387 | |
| 2022-05-03 | 2022-04-29 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | A - Grant | $430.48 | +15 | 2,934 | +0.5% | +$6,457 | |
| 2022-02-01 | 2022-01-28 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | A - Grant | $489.05 | +13 | 2,919 | +0.4% | +$6,358 | |
| 2021-11-02 | 2021-10-29 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | A - Grant | $666.14 | +10 | 2,906 | +0.3% | +$6,661 | |
| D | 2021-08-12 | 2021-08-10 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | M - OptEx | $85.00 | +2,402 | 5,298 | +83% | +$204.2K |
| D | 2021-08-12 | 2021-08-10 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | S - Sale+OE | $679.58 | -2,402 | 2,896 | -45% | -$1.63M |
| 2021-08-03 | 2021-07-30 | IDXX | Idexx Laboratories | JUNIUS DANIEL M | Dir | A - Grant | $678.53 | +10 | 2,896 | +0.3% | +$6,785 |
Purchase Sale Sale after option exercise All abbreviations